POLYPEPTIDE GROUP AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.62 CHF | +4.40% |
|
-3.85% | +78.37% |
Business Summary
Number of employees: 1,273
Sales per Business
| CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Custom Projects
48.2
%
| 141 | 49.8 % | 150 | 48.2 % | +6.75% |
Contract Manufacturing
42.3
%
| 111 | 39.4 % | 132 | 42.3 % | +18.32% |
Generics and Cosmetics
9.5
%
| 30 | 10.7 % | 30 | 9.5 % | -2.08% |
Sales per region
| CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Europe and Asia
71.0
%
| 192 | 67.9 % | 221 | 71.0 % | +15.45% |
United States
29.0
%
| 90 | 32.1 % | 90 | 29.0 % | -0.41% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 12/23/12 | |
| Chief Tech/Sci/R&D Officer | 52 | 01/12/01 | |
Jens Fricke
COO | Chief Operating Officer | 59 | 01/22/01 |
Jane Salik
BRD | Director/Board Member | 71 | 01/06/01 |
Michael Stäheli
IRC | Investor Relations Contact | 59 | 01/21/01 |
| General Counsel | 54 | 01/99/01 | |
Monika Casanova
HRO | Human Resources Officer | 45 | 09/22/09 |
Neil Thompson
SAM | Sales & Marketing | 52 | 01/04/01 |
| General Counsel | 46 | 01/21/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 01/21/01 | |
Peter Wilden
CHM | Chairman | 67 | 01/21/01 |
Jane Salik
BRD | Director/Board Member | 71 | 01/06/01 |
Beat In-Albon
BRD | Director/Board Member | 72 | 01/21/01 |
Philippe Weber
BRD | Director/Board Member | 59 | 01/21/01 |
Erik Schropp
BRD | Director/Board Member | 60 | 01/21/01 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 33,125,001 | 12,958,584 ( 39.12 %) | 155,494 ( 0.4694 %) | 39.12 % |
Company contact information
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
34.46
EUR
Average target price
25.12
EUR
Spread / Average Target
-27.09%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +41.25% | 63TCr | |
| -7.15% | 35TCr | |
| +18.77% | 33TCr | |
| +8.79% | 30TCr | |
| +17.55% | 25TCr | |
| 0.00% | 22TCr | |
| +10.51% | 22TCr | |
| +3.68% | 16TCr | |
| -4.38% | 16TCr |
- Stock Market
- Equities
- PPGN Stock
- 0AAJ Stock
- Company PolyPeptide Group AG
